Key facts
- RadioNano Therapeutics’s last known valuation is $8.3M (Dec 2024).
- It has raised $4.0M.
- Notable investors include Mitsubishi UFJ Capital, SMBC Venture Capital, DBJ Capital, Kyoto University Innovation Capital, CITIC Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for RadioNano Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for RadioNano Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RadioNano Therapeutics
Operator of a research and development firm intended for neutron therapy. The company does the social implementation of neutron capture therapy using highly hydrophilic boron-containing inorganic nanoparticles, enabling customers to use new cancer treatment methods.
- Sector
- Healthcare
- HQ
- Kyoto, Japan
- Founded
- 2024
- Website
- radionano-tx.com/
- Ownership
- Privately Held (backing)
RadioNano Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RadioNano Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RadioNano Therapeutics in its N-PORT filings yet. We sweep new filings monthly.